The impact of race and social vulnerability on head and neck cutaneous squamous cell carcinoma treatment and staging

Arch Dermatol Res. 2024 May 21;316(5):186. doi: 10.1007/s00403-024-02951-z.

Lillian McCampbell^#¹, David Jun Fei-Zhang^#², Daniel Chelius³, Travis Blalock⁴, Jill D'Souza⁵, Jeffrey Rastatter^{2

6}, Anthony Sheyn^{7

8}

¹ Department of Otolaryngology-Head and Neck Surgery, College of Medicine, University of Tennessee Health Science Center, 910 Madison Avenue, Memphis, TN, 38103, USA. lemcc@uthsc.edu.
² Northwestern University Feinberg School of Medicine, 420 E Superior St, Chicago, IL, USA.
³ Department of Otolaryngology-Head and Neck Surgery, Pediatric Thyroid Tumor Program and Pediatric Head and Neck Tumor Program, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
⁴ Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA.
⁵ Division of Pediatric Otolaryngology, Children's Hospital of New Orleans and Louisiana State University, New Orleans, LA, USA.
⁶ Division of Pediatric Otolaryngology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
⁷ Department of Pediatric Otolaryngology, Le Bonheur Children's Hospital, Memphis, TN, USA.
⁸ Department of Pediatric Otolaryngology, St. Jude Children's Research Hospital, Memphis, TN, USA.

^# Contributed equally.

No abstract available

Keywords: Head and neck; Squamous cell carcinoma; Staging; Treatment.

Publication types